We read with interest the paper “Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: from interferon- based to direct acting antivirals era”, and we feel that the combination of effectiveness with a cost analysis is original and increases the awareness about patients with Mixed Cryoglobulinaemia (MC).
Mixed cryoglobulinaemia: An important but frequently unrecognized and underestimated HCV-related condition in the real life practice
Segala D.Membro del Collaboration Group
2018
Abstract
We read with interest the paper “Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: from interferon- based to direct acting antivirals era”, and we feel that the combination of effectiveness with a cost analysis is original and increases the awareness about patients with Mixed Cryoglobulinaemia (MC).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
liv.13490.pdf
solo gestori archivio
Descrizione: Full text ahead of print
Tipologia:
Full text (versione editoriale)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
152.75 kB
Formato
Adobe PDF
|
152.75 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
